SCHEMBL10028091

SCHEMBL10028091

Cc1ccccc1N(c1cc2ccc3oc4cc(N(c5ccccc5C)c5ccccc5C)cc5ccc6oc(c1)c2c3-c6c54)c1ccccc1C

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10028095 0.80 ALDH1A1 (0.33) MAPT
SCHEMBL15852364 0.78 MAPT (0.33) TP53MAPTSMN1; SMN2
SCHEMBL10028100 0.78 L3MBTL1 (0.34) TP53SMN1; SMN2
SCHEMBL10028098 0.76 SIGMAR1 (0.35) MAPT
SCHEMBL10028193 0.75 NPC1 (0.31) MAPTSMN1; SMN2
SCHEMBL21870438 0.75 DYRK1A (0.38) TP53MAPTSMN1; SMN2
SCHEMBL24822820 0.74 NPC1 (0.31) TP53MAPTSMN1; SMN2
SCHEMBL17791999 0.73 ALDH1A1 (0.33)
SCHEMBL10028113 0.73
SCHEMBL21870458 0.72 DYRK1A (0.38) TP53MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046915-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-12-02 EP disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 TP53 4429/4885MAPT 567/4885SMN1; SMN2 3914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.